These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia]. Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031 [TBL] [Abstract][Full Text] [Related]
30. [Progress in the treatment of hairy cell leukemia. Subcutaneous administration of 2-chloro-deoxy-adenosine for 7 days]. Heldal D; Tjønnfjord GE; Evensen SA; Juliusson G Tidsskr Nor Laegeforen; 1994 Mar; 114(7):800-3. PubMed ID: 7912011 [TBL] [Abstract][Full Text] [Related]
31. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. Piro LD; Carrera CJ; Carson DA; Beutler E N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613 [TBL] [Abstract][Full Text] [Related]
32. Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95. Zenhäusern R; Von Rohr A; Rufibach K; Solenthaler M; Meyer-Monard S; Gratwohl A; Hess U; Bargetzi MJ; Kovacsovic T; Leoncini L; Tobler A; Leuk Lymphoma; 2009 Jan; 50(1):133-6. PubMed ID: 19152171 [No Abstract] [Full Text] [Related]
33. Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia. Goldschmidt N; Ganzel C; Attias D; Gatt M; Polliack A; Tadmor T Acta Haematol; 2014; 132(1):118-21. PubMed ID: 24557414 [No Abstract] [Full Text] [Related]
34. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence. Else M; Dearden CE; Matutes E; Forconi F; Lauria F; Ahmad H; Kelly S; Liyanage A; Ratnayake V; Shankari J; Whalley I; Catovsky D Leuk Lymphoma; 2011 Jun; 52 Suppl 2():75-8. PubMed ID: 21504288 [TBL] [Abstract][Full Text] [Related]
35. Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel. Inbar M; Herishanu Y; Goldschmidt N; Bairey O; Yuklea M; Shvidel L; Fineman R; Aviv A; Ruchlemer R; Braester A; Najib D; Rouvio O; Shaulov A; Greenbaum U; Polliack A; Tadmor T Anticancer Res; 2018 Nov; 38(11):6423-6429. PubMed ID: 30396967 [TBL] [Abstract][Full Text] [Related]
37. Bladder stones formation eight months after treatment of hairy-cell leukemia with 2-chloro-deoxyadenosine: a case report. Bessa O Conn Med; 1995 Jun; 59(6):331. PubMed ID: 7648851 [No Abstract] [Full Text] [Related]
38. Remission of psoriasis after treatment with interferon-alfa and 2-chlordeoxyadenosine for hairy cell leukemia. Ilyas W; Myers D; Mann R; Seraly MP J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):316-8. PubMed ID: 10426918 [TBL] [Abstract][Full Text] [Related]
39. Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). Zenhäusern R; Schmitz SF; Solenthaler M; Heim D; Meyer-Monard S; Hess U; Leoncini L; Bargetzi M; Rufener B; Tobler A Leuk Lymphoma; 2009 Sep; 50(9):1501-11. PubMed ID: 19672771 [TBL] [Abstract][Full Text] [Related]
40. Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission. Girardi K; Paviglianiti A; Cirillo M; Bianchi A; Gherardi G; Annibali O; Cerchiara E; Marchesi F; Tomarchio V; Miglio C; Tirindelli M; Onetti Muda A; Avvisati G J Clin Exp Hematop; 2012; 52(1):31-4. PubMed ID: 22706528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]